Therapeutic Uses
Anti-Thrombotics
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-7a-hydroxy-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Yes -Refer MSDS for accurate information
Prasugrel Hydroxy Thiolactone is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Prasugrel Hydroxy Thiolactone usage and description
Prasugrel Hydroxy Thiolactone is a chemical compound that belongs to the thienopyridine class of antiplatelet agents. It is used as an antiplatelet medication to prevent blood clots formation in patients with acute coronary syndrome, including those undergoing percutaneous coronary intervention (PCI). Prasugrel Hydroxy Thiolactone works by inhibiting the platelet activation and aggregation process, which is a critical step in the formation of blood clots.
Chemically, Prasugrel Hydroxy Thiolactone is a prodrug, which means it is inactive until it is metabolized in the liver to its active form, Prasugrel. This conversion process involves hydrolysis of the thiolactone ring, which releases the active metabolite. The active metabolite of Prasugrel Hydroxy Thiolactone irreversibly binds to the P2Y12 receptor on the platelet surface, which inhibits ADP-induced platelet aggregation and reduces the risk of thrombotic events.
Prasugrel Hydroxy Thiolactone is available in the form of oral tablets, and the recommended dosage depends on the patient's weight and medical condition. It is contraindicated in patients with a history of bleeding, stroke, or transient ischemic attack (TIA). Prasugrel Hydroxy Thiolactone may also interact with other medications, such as anticoagulants and nonsteroidal anti-inflammatory drugs (NSAIDs), which can increase the risk of bleeding.
In conclusion, Prasugrel Hydroxy Thiolactone is a potent antiplatelet medication that effectively prevents blood clot formation in patients with acute coronary syndrome. Its chemical structure and mechanism of action are critical in understanding its pharmacological properties and potential interactions with other medications.
